Aura Biosciences Inc (AURA NASDAQ) stock market data APIs
$8.2378
0.55(6.7%)
as of May 6, 2026
Try our APIs with
free plan!
Aura Biosciences Inc Financial Data Overview
Price chart is built with
Anychart
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. It focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer. The company was incorporated in 2009 and is headquartered in Boston, Massachusetts.
Prev. Close
8.2378
Open
8.788
High
8.9244
Low
8.1775
52 wk Range
4.345-9.535
Market Cap
924 M
Shares Outstanding
104 M
EPS
0
Beta
0.371
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Aura Biosciences Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Aura Biosciences Inc data using free add-ons & libraries
Get Aura Biosciences Inc Fundamental Data
Aura Biosciences Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -111 662 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-07
- EPS/Forecast: -0.52
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Aura Biosciences Inc News
New
Aura Announces Pricing Of Over 39 Mln Shares At $6 Per Share
(RTTNews) - Aura Biosciences Inc. (AURA), a clinical-stage biotechnology company, announced on Monday the pricing of its underwritten public offering of 39.59 million shares of common stock at $6 per ...
Aura Biosciences Announces Pricing of $260 Million Public Offering of Common Stock and Pre-funded Warrants
BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (“Aura”) (Nasdaq: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preser...
TMX Group Equity Financing Statistics - March 2026
Toronto Stock Exchange, TSX Venture Exchange Toronto, Ontario--(Newsfile Corp. - April 9, 2026) - TMX Group today announced its financing activity on Toronto Stock Exchange (TSX) and TSX Venture Exch...
Aura Biosciences to Participate in the 8th Annual Evercore Healthcare Conference
BOSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ fun...
Get Aura Biosciences Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
